Cancer Research Landon Prizes for Basic and Translational Cancer Research Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. W.
Right arrow Articles by Povirk, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. W.
Right arrow Articles by Povirk, L. F.
[Cancer Research 63, 22-24, January 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Requirement for XRCC4 and DNA Ligase IV in Alignment-based Gap Filling for Nonhomologous DNA End Joining in Vitro1

Jae Wan Lee, Steven M. Yannone, David J. Chen and Lawrence F. Povirk2

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298 [J. W. L., L. F. P.], and Department of Cell and Molecular Biology, Lawrence Berkeley National Laboratory, Berkeley, California 94720 [S. M. Y., D. J. C.]

In the nonhomologous end joining pathway of DNA double-strand break repair, the ligation step is catalyzed by a complex of XRCC4 and DNA ligase IV. Extracts of CHO-K1 cells are able to accurately rejoin a site-specific free radical-mediated double-strand break with partially complementary overhangs, by a mechanism involving alignment-based gap filling followed by ligation. Extracts of XR-1 cells, which lack XRCC4 and DNA ligase IV, carried out neither gap filling nor ligation. Supplementation of the extracts with recombinant XRCC4/ligase IV, but not with XRCC4 alone, restored gap filling and accurate end joining. The results imply that XRCC4 and ligase IV are essential for alignment-based gap filling, as well as for final ligation of the breaks.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
L. Schulte-Uentrop, R. A. El-Awady, L. Schliecker, H. Willers, and J. Dahm-Daphi
Distinct roles of XRCC4 and Ku80 in non-homologous end-joining of endonuclease- and ionizing radiation-induced DNA double-strand breaks
Nucleic Acids Res., May 1, 2008; 36(8): 2561 - 2569.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R.-Z. Zhou, L. Blanco, M. Garcia-Diaz, K. Bebenek, T. A. Kunkel, and L. F. Povirk
Tolerance for 8-oxoguanine but not thymine glycol in alignment-based gap filling of partially complementary double-strand break ends by DNA polymerase {lambda} in human nuclear extracts
Nucleic Acids Res., May 1, 2008; 36(9): 2895 - 2905.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
S. Kuhfittig-Kulle, E. Feldmann, A. Odersky, A. Kuliczkowska, W. Goedecke, A. Eggert, and P. Pfeiffer
The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV
Mutagenesis, May 1, 2007; 22(3): 217 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Despras, P. Pfeiffer, B. Salles, P. Calsou, S. Kuhfittig-Kulle, J. F. Angulo, and D. S.F. Biard
Long-term XPC Silencing Reduces DNA Double-Strand Break Repair
Cancer Res., March 15, 2007; 67(6): 2526 - 2534.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. R. Jones, D. A. Gewirtz, S. M. Yannone, S. Zhou, D. G. Schatz, K. Valerie, and L. F. Povirk
Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein
Mol. Cancer Ther., October 1, 2005; 4(10): 1541 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Q. Pan-Hammarstrom, A.-M. Jones, A. Lahdesmaki, W. Zhou, R. A. Gatti, L. Hammarstrom, A. R. Gennery, and M. R. Ehrenstein
Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells
J. Exp. Med., January 18, 2005; 201(2): 189 - 194.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
M. McVey, D. Radut, and J. J. Sekelsky
End-Joining Repair of Double-Strand Breaks in Drosophila melanogaster Is Largely DNA Ligase IV Independent
Genetics, December 1, 2004; 168(4): 2067 - 2076.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. W. Lee, L. Blanco, T. Zhou, M. Garcia-Diaz, K. Bebenek, T. A. Kunkel, Z. Wang, and L. F. Povirk
Implication of DNA Polymerase {lambda} in Alignment-based Gap Filling for Nonhomologous DNA End Joining in Human Nuclear Extracts
J. Biol. Chem., January 2, 2004; 279(1): 805 - 811.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Bebenek, M. Garcia-Diaz, L. Blanco, and T. A. Kunkel
The Frameshift Infidelity of Human DNA Polymerase {lambda}: IMPLICATIONS FOR FUNCTION
J. Biol. Chem., September 5, 2003; 278(36): 34685 - 34690.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.